Inventor
Gene M. Dubowchik
Inventor
Middlefield, CT, US
Overview
Patents· 28 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes20%
A01KAnimal husbandry5%
C07KPeptides5%
C12NMicroorganisms or enzymes5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
PatentTitleYear
11,053,258Pyrimidine carboxamides as GSK-3 inhibitors202110,774,086GSK-3 inhibitors202010,752,609GSK-3 inhibitors202010,266,578Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof20199,809,573'Substituted pyridine derivatives useful as GSK-3 inhibitors'20179,718,804'GSK-3 inhibitors'20178,748,429'CGRP receptor antagonists'20148,481,546'CGRP receptor antagonist'20138,314,117'CGRP receptor antagonists'20127,842,808'Anti-migraine spirocycles'20107,772,244'Therapeutic agents for the treatment of migraine'20107,754,732'Spirocyclic anti-migraine compounds'20107,569,578'Heterocyclic anti-migraine agents'20097,470,680'Constrained compounds as CGRP-receptor antagonists'20087,314,883'Anti-migraine treatments'20087,244,746'Imidazolyl derivatives as corticotropin releasing factor inhibitors'20077,238,699'Imidazolyl derivatives as corticotropin releasing factor inhibitors'20077,220,862'Calcitonin gene related peptide receptor antagonists'20077,125,990'Imidazolyl derivatives as corticotropin releasing factor inhibitors'20066,908,931'Tetrahydroisoquinoline derivatives as melatonin MT2 antagonists'20056,888,004'Imidazolyl derivatives as corticotropin releasing factor inhibitors'20056,818,643'Neurotrophic bicyclic diamides'20046,759,509'Branched peptide linkers'20046,515,005'Substituted azole derivatives as inhibitors of corticotropin releasing factor'20036,239,146'Neurotrophic difluoroamide agents'20016,228,872'Neurotrophic diamide and carbamate agents'20016,214,345'Lysosomal enzyme-cleavable antitumor drug conjugates'20016,096,762'Neurotrophic difluoroamide agents'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000–2021Patents assigned to BRISTOL MYERS SQUIBB CO (28)· patent assignee history
2000–2021Based in Middlefield, CT, US· patent location history
2012–2014Patents assigned to DUBOWCHIK GENE M (3)· patent assignee history
2012–2014Patents assigned to MACOR JOHN E (3)· patent assignee history
2012–2014Patents assigned to LUO GUANGLIN (2)· patent assignee history
2013Patents assigned to CHATURVEDULA PRASAD V (1)· patent assignee history
2014Based in Middlefleid, CT, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 28 | 2000–2021 |
| DUBOWCHIK GENE Mself | 3 | 2012–2014 |
| MACOR JOHN E | 3 | 2012–2014 |
| LUO GUANGLIN | 2 | 2012–2014 |
| CHATURVEDULA PRASAD V | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Middlefield, CT, US | 27 | 2000–2021 |
| Middlefleid, CT, US | 1 | 2014 |